On behalf of our sponsors at Arcutis Biotherapeutics, we're learning more about Plaque Psoriasis, the chronic, inflammatory skin disease that affects many people and a new topical treatment that may ...

From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction. Join Drs Feldman and Armstrong as they discuss.

Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter. The healthcare-products company said Tuesday it now expects adjusted per-share ...

A global comparison of psoriatic arthritis guidelines reveals differences in treatment sequencing and domain-specific strategies, with all emphasizing treat-to-target goals and comorbidity management.

Boehringer Ingelheim set to receive EUR 90 million as upfront payment, along with milestone payments and tiered royalties.

Johnson and Johnson beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as ...

Quarterly pharmaceutical sales surpassed $15 billion for the first time as strong performance from J&J's cancer medicines offset slumping Stelara sales.

Kayakalp Global is revolutionizing autoimmune skin disorder treatment in India, focusing on root causes rather than cosmetic solutions.

Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research repo ...

C, joins Integrated Dermatology of Reston, bringing 20 years of dermatology experience to patients across Northern Virginia.